Sort
78,016 grants matching “breast cancer”
Molecular origins and impact of APOBEC3 mutagenesis in cancer
$629,354John Maciejowski · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Core A: Biospecimen and High-Dimensional Data Management Core
$629,241Shelley S Tworoger · Brigham And Women'S Hospital · P01 · FY2017 · CA
Core A: Biospecimen and High-Dimensional Data Management Core
$629,241Shelley S Tworoger · Brigham And Women'S Hospital · P01 · FY2018 · CA
Ethnicity and Nativity in Cancer - Latino & Asian Enclaves: The ENCLAVE Study
$629,237Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2020 · CA
Radiogenomic Biomarkers of Breast Cancer Recurrence
$629,228Despina Kontos · University Of Pennsylvania · R01 · FY2021 · CA
Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors
$629,227Anita Y Kinney · University Of New Mexico Health Scis Ctr · R01 · FY2017 · CA
Prevention of Osteoporosis in Breast Cancer Survivors
$629,179University Of Nebraska Medical Center · R01 · FY2005 · NR
Longitudinal investigation of sociocultural and behavioral influences on symptom management, biological response, and functioning between Chinese and White breast cancer survivors.
$629,169Judy Huei-Yu Wang · Georgetown University · R01 · FY2022 · CA
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
$629,131Elizabeth Marjorie Cespedes Feliciano · Kaiser Foundation Research Institute · R01 · FY2023 · CA
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
$629,096Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$629,038William E Gillanders · Washington University · R01 · FY2019 · CA
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$628,972William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Targeting the PI3K Signaling Axis
$628,967Thomas M Roberts · Massachusetts General Hospital · P50 · FY2015 · CA
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
$628,869Melanie R Palomares · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
2D and 3D Contrast-enhanced Ultrasound Evaluation of Chemoembolization.
$628,857John Eisenbrey · Thomas Jefferson University · R01 · FY2025 · CA
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia
$628,845John Eisenbrey · Thomas Jefferson University · R01 · FY2021 · EB
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial
$628,815Christine Rini · Northwestern University At Chicago · R01 · FY2023 · CA
RESEARCH CORE
$628,788Catarina I Kiefe · University Of Alabama At Birmingham · P60 · FY2011 · MD
Modeling response to MAPK Inhibitors
$628,772Wolfgang Michael Korn · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2010 · CA
RCT of Primary Care-based Patient Navigation-Activation
$628,769Kevin Fiscella · University Of Rochester · U01 · FY2006 · CA
Thermoregulatory Physiology of Menopausal Hot Flashes
$628,753Fiona C Baker · Sri International · R21 · FY2025 · AG
LEGACY: A cohort of youth in families from the Breast Cancer Family Registry
$628,727Mary Beth Terry · Columbia University Health Sciences · R01 · FY2015 · CA
Commercial development of Src kinase inhibitors for oncology
$628,719Allen Barnett · Kinex Pharmaceuticals, Llc · R44 · FY2009 · CA
Improvement of microcalcification detection in digital breast tomosynthesis
$628,690Heang-Ping Chan · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Dynamics in the Tissue State: From Normal to Tumor and Back
$628,639Jan T. Liphardt · University Of California Berkeley · U54 · FY2011 · CA